Saturday 17 October 2026 Export SBFM’s income statement to Excel — free account

Sunshine Biopharma, Inc.

SBFM Healthcare Drug Manufacturers Specialty & Generic

Sunshine Biopharma, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $36.3 million, up 4.11% from fiscal 2024. In the quarter to June 2026, revenue fell 1.56%, EPS grew 70.5% and free cash flow grew 49.4%, each against the same quarter a year earlier. Revenue growth for five consecutive years.

0.22 0.01 −4.35%

Follow SBFM

Alert me

Market cap: $990.0K
P/E: 0.0×
Fwd P/E: −0.4×
Dividend yield: —
F-score: 4/9
Altman Z: −1.72
Beneish M: −2.96
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
Piotroski F-Score Full definition →	+8 more TTM periods Free account	3	4	4	4
ROE Full definition →		(24.35%)	(25.69%)	(27.33%)	(21.93%)
ROA Full definition →		(19.47%)	(19.71%)	(21.15%)	(17.78%)
ROIC Full definition →		(27.38%)	(27.97%)	(27.08%)	(26.67%)
Return on Tangible Assets Full definition →		(27.35%)	(28.50%)	(31.10%)	(22.85%)
Average Days of Receivables Full definition →		40.64	34.78	41.25	41.67
Free Cash Flow per Share Full definition →		(17.57)	(14.84)	(13.12)	(4.06)
Free Cash Flow Full definition →		(8.00)	(6.17)	(6.44)	(5.54)
Capital Expenditures Full definition →		(0.88)	(0.84)	(0.73)	(0.18)
Other line items
Cash ROIC Full definition →		(23.89%)	(19.18%)	(22.64%)	(13.41%)
Accounts Receivable Turnover Full definition →		10.12	9.91	9.52	9.27
Accounts Payable Turnover Full definition →		4.86	4.29	4.70	5.11
Inventory Turnover Full definition →		2.09	1.94	1.90	1.96
Average Days of Payables Full definition →		89.59	85.96	78.33	71.89
Days of Inventory on Hand Full definition →		205.30	204.46	202.06	179.59
Tax Rate Full definition →		(0.08)	0.00	0.01	0.00
Research and Development Expense of Revenue Full definition →		1.82%	1.66%	1.19%	0.67%
Selling, General and Administrative Expense of Revenue Full definition →		43.53%	48.33%	48.65%	48.29%
Share Based Compensation of Revenue Full definition →		0.00%	0.00%	0.00%	0.27%
Operating CF/Net income Full definition →		1.19	0.89	0.95	0.92
Depreciation/Fixed assets Full definition →		3.20	3.73	4.05	2.17
Capex/Depreciation Full definition →		(0.46)	(0.40)	(0.35)	(0.18)
Revenue per Share Full definition →		81.92	87.34	72.35	25.89
Operating CF per Share Full definition →		(15.63)	(12.82)	(11.64)	(3.92)
Capex per Share Full definition →		(1.94)	(2.01)	(1.49)	(0.13)
Capex to Sales Full definition →		0.02	0.02	0.02	0.01

Show all line items

Columns are period end dates

Stockrow Weekly